TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06391892 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06262438 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05609357 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study NCT04645069 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05330871 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04476576 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT04476576 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00012441 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06324474 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05900076 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06692894 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT06715449 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06718153 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT06718153 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06718153 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study NCT06718153 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05496907 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05496907 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05257499 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT05089084 — Predictive Biomarker (PRD): APOC3 mRNA
Genes: APOC3
Study NCT05246514 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05632432 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05162690 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05573035 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05559346 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05905536 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05727397 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05775900 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06676800 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00002322 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05691387 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05753462 — Surrogate Endpoint (SUR): Skeletal muscle dystrophin
Study NCT05981326 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05981326 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05981326 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06339489 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06231069 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05643001 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05089370 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05160701 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05160701 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05973006 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04619004 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06340230 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06340230 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05791864 — Predictive Biomarker (PRD): Tripeptidyl-peptidase I
Genes: TPP1; CLN2; GIG1; UNQ267/PRO304
Study NCT06513546 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05905783 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06717646 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06715462 — Predictive Biomarker (PRD): PDPN mRNA
Genes: PDPN; GP36; PSEC0003; PSEC0025
Study NCT05498584 — Predictive Biomarker (PRD): LOXL2 mRNA
Genes: LOXL2
Study NCT00012506 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05095298 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05189210 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05189210 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03070093 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05261828 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT06334809 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT06334809 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT05832892 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05832892 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT05434611 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study NCT06473077 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study NCT06071624 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06113692 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06467253 — Predictive Biomarker (PRD): CR1 mRNA
Genes: CR1; C3BR
Study NCT06467253 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT06467253 — Predictive Biomarker (PRD): TREM2 mRNA
Genes: TREM2
Study NCT06467253 — Predictive Biomarker (PRD): ABCA7 mRNA
Genes: ABCA7
Study NCT04332666 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04332666 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05619016 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06042439 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04984395 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT05794737 — Predictive Biomarker (PRD): INHBA mRNA
Genes: INHBA
Study NCT05562115 — Predictive Biomarker (PRD): PAX6 mRNA
Genes: PAX6; AN2
Study NCT04979988 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04856982 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04203316 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT05245786 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05510544 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05510544 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT06054568 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT05325203 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06282861 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT05404763 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT06160323 — Predictive Biomarker (PRD): CGN mRNA
Genes: CGN; KIAA1319
Study NCT05428319 — Predictive Biomarker (PRD): STEAP1 mRNA
Genes: STEAP1; PRSS24; STEAP
Study NCT05932173 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05944822 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06690775 — Predictive Biomarker (PRD): CLDN6 mRNA
Genes: CLDN6; UNQ757/PRO1488
Study NCT06716853 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06718062 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT06718062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06717529 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06719050 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06719050 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06719050 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05390164 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT05390164 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT06117007 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06533878 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04804124 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05857566 — Predictive Biomarker (PRD): RDX mRNA
Genes: RDX
Study NCT05245539 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05783895 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study NCT04927676 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04941105 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06175780 — Predictive Biomarker (PRD): KY mRNA
Genes: KY
Study NCT06159257 — Predictive Biomarker (PRD): A2M mRNA
Genes: A2M; CPAMD5; FWP007
Study NCT06159257 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study NCT06187324 — Predictive Biomarker (PRD): SERPINF2 mRNA
Genes: SERPINF2; AAP; PLI
Study NCT06187324 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT06187324 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT06187324 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT06187324 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT04077151 — Predictive Biomarker (PRD): SRY mRNA
Genes: SRY; TDF
Study NCT00000646 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05796258 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT06135948 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT06350448 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05598151 — Predictive Biomarker (PRD): EZH2
Genes: EZH1; ENX-1; KMT6; KMT6A
Study NCT05305924 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06640387 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05698303 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05692908 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04852302 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study NCT06416228 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT05254171 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study NCT06333717 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05545943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06178978 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05375188 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05480228 — Predictive Biomarker (PRD): PDPN mRNA
Genes: PDPN; GP36; PSEC0003; PSEC0025
Study NCT05165082 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04949035 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06617286 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04906161 — Surrogate Endpoint (SUR): Serum calcium
Study NCT06014827 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06714968 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05576025 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study NCT06075212 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06225427 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06675994 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06676553 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06676917 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT06676917 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT05771714 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05799261 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06461624 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT05370430 — Predictive Biomarker (PRD): TNFRSF13C mRNA
Genes: TNFRSF13C; BAFFR; BR3
Study NCT05759000 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05759000 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05215925 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05385211 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05133063 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05450835 — Predictive Biomarker (PRD): OGT mRNA
Genes: OGT
Study NCT06399029 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05485402 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT06397963 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05030077 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT06504368 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04333615 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06063681 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT06176716 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05187260 — Predictive Biomarker (PRD): Chromosome 5q
Study NCT00000857 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000857 — Safety Biomarker (SAF): Interleukin 12
Study NCT05881577 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05983107 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05983107 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05983107 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05983107 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06555159 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05074836 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05657496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05657496 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT05657496 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT06405880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05787964 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05826457 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT05144776 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05949242 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT06101992 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT00002436 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05112848 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00893854 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00893854 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05019417 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT05019417 — Predictive Biomarker (PRD): SLC16A2 mRNA
Genes: SLC16A2; MCT7; MCT8; XPCT
Study NCT04988841 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04942249 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06099639 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT05572879 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06717113 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06718049 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT06715046 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04846387 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study NCT06315049 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05965973 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05774951 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05774951 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04739111 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04794036 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05217459 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT04806061 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT03768310 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05528341 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05338762 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05309044 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05074017 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04718350 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT06481345 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04913779 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06312189 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01297101 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01964937 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04263480 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT04263480 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study NCT06666972 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT06676436 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06676436 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06676774 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT05701553 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05857436 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06395870 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05394896 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05201976 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04883255 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study NCT05581745 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT04598321 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04598321 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05007327 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04909346 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT05578053 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05578053 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06279728 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05474105 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05474105 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05740527 — Predictive Biomarker (PRD): GNS mRNA
Genes: GNS
Study NCT05499351 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06136143 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06647641 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT06167967 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05689879 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05123300 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04935255 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04923243 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04923243 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study NCT05817097 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04767698 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT06611839 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06611839 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study NCT06676215 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT06676124 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT06178367 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04735315 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06512610 — Predictive Biomarker (PRD): ELN mRNA
Genes: ELN
Study NCT06315777 — Predictive Biomarker (PRD): GREM1 mRNA
Genes: GREM1; CKTSF1B1; DAND2; DRM; PIG2
Study NCT06315777 — Predictive Biomarker (PRD): HAS2 mRNA
Genes: HAS2
Study NCT06315777 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study NCT06307249 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06307249 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06307249 — Predictive Biomarker (PRD): VEGF
Genes: VEGFA; VEGF-A; VPF
Study NCT06307249 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05715957 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05715957 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT06182397 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05842525 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT05686434 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04369495 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT06440603 — Predictive Biomarker (PRD): KLF1 mRNA
Genes: KLF1; EKLF
Study NCT05842486 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT04780529 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART